Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-10-23

Clinical Trial Update: Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure [Phase 1]

View source ↗

Summary

Phase I study examining interaction between istaroxime and digoxin in subjects with stable heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIGOXIN (Digoxin)
  • Istaroxime (istaroxime)

Snippet

Sponsor: Debiopharm International SA | Conditions: Heart Failure | Phase 1 | Status: WITHDRAWN